Medifast (NYSE:MED) Director Scott Schlackman Buys 2,500 Shares

Medifast Inc (NYSE:MED) Director Scott Schlackman acquired 2,500 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were bought at an average price of $12.53 per share, for a total transaction of $31,325.00. Following the transaction, the director owned 30,549 shares of the company’s stock, valued at $382,778.97. This trade represents a 8.91% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Scott Schlackman also recently made the following trade(s):

• On Friday, May 8th, Scott Schlackman bought 2,500 shares of Medifast stock. The stock was bought at an average cost of $12.65 per share, with a total value of $31,625.00.

Medifast Trading Up 1.3%

Shares of MED opened at $12.56 on Wednesday. The firm has a fifty day simple moving average of $10.66 and a two-hundred day simple moving average of $11.09. The firm has a market cap of $139.62 million, a PE ratio of -6.86 and a beta of 0.55. Medifast Inc has a 1-year low of $9.22 and a 1-year high of $15.46.

Medifast (NYSE:MED) last issued its quarterly earnings data on Monday, May 4th. The specialty retailer reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.36. The company had revenue of $76.04 million during the quarter, compared to analyst estimates of $69.20 million. Medifast had a negative return on equity of 4.80% and a negative net margin of 5.78%.Medifast has set its FY 2026 guidance at -2.750–1.550 EPS and its Q2 2026 guidance at -1.000–0.500 EPS. As a group, research analysts forecast that Medifast Inc will post -2 EPS for the current fiscal year.

Institutional Trading of Medifast

Several institutional investors and hedge funds have recently made changes to their positions in MED. BNP Paribas Financial Markets grew its holdings in Medifast by 103.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,338 shares of the specialty retailer’s stock worth $32,000 after acquiring an additional 1,187 shares in the last quarter. Quantbot Technologies LP purchased a new stake in shares of Medifast in the 3rd quarter worth approximately $37,000. Intesa Sanpaolo Wealth Management purchased a new position in Medifast during the fourth quarter valued at approximately $47,000. State of Wyoming bought a new stake in shares of Medifast in the 4th quarter valued at about $59,000. Finally, Strs Ohio acquired a new stake in Medifast in the first quarter worth about $78,000. 95.51% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

MED has been the topic of several research reports. Weiss Ratings cut shares of Medifast from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 6th. Wall Street Zen raised shares of Medifast from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. Finally, Stephens decreased their price objective on shares of Medifast from $15.00 to $12.00 and set an “equal weight” rating for the company in a report on Thursday, February 19th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Medifast presently has an average rating of “Reduce” and an average price target of $12.00.

Medifast Company Profile

Medifast, Inc (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight‐loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight‐management solutions.